Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors

Joshua P. Loh, MedStar Washington Hospital Center
Lakshmana K. Pendyala, MedStar Washington Hospital Center
Hironori Kitabata, MedStar Washington Hospital Center
Rebecca Torguson, MedStar Washington Hospital CenterFollow
Fang Chen, MedStar Washington Hospital Center
Kenneth M. Kent, MedStar Washington Hospital CenterFollow
Lowell F. Satler, MedStar Washington Hospital CenterFollow
William O. Suddath, MedStar Washington Hospital Center
Augusto D. Pichard, MedStar Washington Hospital Center
Ron Waksman, MedStar Washington Hospital Center

Document Type

Journal Article

Publication Date

3-15-2013

Journal

American Journal of Cardiology

Volume

Volume 111, Issue 6

Inclusive Pages

841-845

Keywords

Acute Coronary Syndrome--therapy; Percutaneous Coronary Intervention; Piperazines--administration & dosage; Platelet Aggregation Inhibitors--administration & dosage; Purinergic P2Y Receptor Antagonists--administration & dosage; Thiophenes--administration & dosage; Ticlopidine--analogs & derivatives

APA Citation

Loh, J. P., Pendyala, L. K., Kitabata, H., Torguson, R., Chen, F., Kent, K. M., . . . Waksman, R. (2013). Safety of reloading prasugrel in addition to clopidogrel loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention. American Journal of Cardiology, 111(6), 841-845.

Peer Reviewed

1